Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24747429)

  • 1. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
    Nolen BM; Brand RE; Prosser D; Velikokhatnaya L; Allen PJ; Zeh HJ; Grizzle WE; Huang Y; Lomakin A; Lokshin AE
    PLoS One; 2014; 9(4):e94928. PubMed ID: 24747429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Moore LE; Pfeiffer RM; Zhang Z; Lu KH; Fung ET; Bast RC
    Cancer; 2012 Jan; 118(1):91-100. PubMed ID: 21717433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
    Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
    Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarker panels for the detection of pancreatic cancer.
    Brand RE; Nolen BM; Zeh HJ; Allen PJ; Eloubeidi MA; Goldberg M; Elton E; Arnoletti JP; Christein JD; Vickers SM; Langmead CJ; Landsittel DP; Whitcomb DC; Grizzle WE; Lokshin AE
    Clin Cancer Res; 2011 Feb; 17(4):805-16. PubMed ID: 21325298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.
    Poruk KE; Firpo MA; Scaife CL; Adler DG; Emerson LL; Boucher KM; Mulvihill SJ
    Pancreas; 2013 Mar; 42(2):193-7. PubMed ID: 23407481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
    Zhu CS; Pinsky PF; Cramer DW; Ransohoff DF; Hartge P; Pfeiffer RM; Urban N; Mor G; Bast RC; Moore LE; Lokshin AE; McIntosh MW; Skates SJ; Vitonis A; Zhang Z; Ward DC; Symanowski JT; Lomakin A; Fung ET; Sluss PM; Scholler N; Lu KH; Marrangoni AM; Patriotis C; Srivastava S; Buys SS; Berg CD;
    Cancer Prev Res (Phila); 2011 Mar; 4(3):375-83. PubMed ID: 21372037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Feasibility of Serum Multiple Tumor Markers Test Between Patients with Primary Pancreatic Cancer and Those with Benign Pancreatic Cystic Disease.
    Lee JH
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer.
    Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S
    Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.
    Franklin O; Jonsson P; Billing O; Lundberg E; Öhlund D; Nyström H; Lundin C; Antti H; Sund M
    Ann Surg; 2018 Apr; 267(4):775-781. PubMed ID: 28425921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of blood biomarker candidates for detection of pancreatic cancer.
    Chen R; Crispin DA; Pan S; Hawley S; McIntosh MW; May D; Anton-Culver H; Ziogas A; Bronner MP; Brentnall TA
    Pancreas; 2010 Oct; 39(7):981-8. PubMed ID: 20467349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
    Makawita S; Dimitromanolakis A; Soosaipillai A; Soleas I; Chan A; Gallinger S; Haun RS; Blasutig IM; Diamandis EP
    BMC Cancer; 2013 Sep; 13():404. PubMed ID: 24007603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.
    Firpo MA; Gay DZ; Granger SR; Scaife CL; DiSario JA; Boucher KM; Mulvihill SJ
    World J Surg; 2009 Apr; 33(4):716-22. PubMed ID: 19082654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.
    Bünger S; Laubert T; Roblick UJ; Habermann JK
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):375-89. PubMed ID: 21193998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.
    Staal B; Liu Y; Barnett D; Hsueh P; He Z; Gao C; Partyka K; Hurd MW; Singhi AD; Drake RR; Huang Y; Maitra A; Brand RE; Haab BB
    Clin Cancer Res; 2019 May; 25(9):2745-2754. PubMed ID: 30617132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel serum tumor marker, RCAS1, in pancreatic diseases.
    Yamaguchi K; Enjoji M; Nakashima M; Nakamuta M; Watanabe T; Tanaka M
    World J Gastroenterol; 2005 Sep; 11(33):5199-202. PubMed ID: 16127752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Early Check-Up of Carbohydrate Antigen 19-9 Levels for Pancreatic Cancer Screening in Asymptomatic New-Onset Diabetic Patients.
    Choe JW; Kim JS; Kim HJ; Hwang SY; Joo MK; Lee BJ; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT
    Pancreas; 2016; 45(5):730-4. PubMed ID: 26646277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.